Stockscreener 앱 받기
13.64
9.65%
1.20
시간 외 거래:
13.77
0.13
+0.95%
전일 마감가:
$12.44
열려 있는:
$12.56
하루 거래량:
2.61M
Relative Volume:
0.96
시가총액:
$1.56B
수익:
$631.73M
순이익/손실:
$-239.78M
주가수익비율:
-6.7525
EPS:
-2.02
순현금흐름:
$-33.45M
1주 성능:
-0.94%
1개월 성능:
+16.68%
6개월 성능:
+64.93%
1년 성능:
-14.91%
1일 변동 폭
$12.44
$13.85
1주일 범위
$12.34
$13.86
52주 변동 폭
$6.78
$18.21
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.64 | 1.55B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
Sumitomo Mitsui Trust Group, Inc. Adjusts Holdings in 10x Genomi - GuruFocus
Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe investment in uncertain marketsExit Point & Verified Short-Term Trading Plans - newser.com
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard
ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus
10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma
10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan
Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - Fundação Cultural do Pará
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyEarnings Risk Summary & Short-Term Trading Alerts - newser.com
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com
How geopolitical tensions affect 10x Genomics Inc. stockDividend Hike & Risk Controlled Daily Trade Plans - newser.com
Advanced analytics toolkit walkthrough for 10x Genomics Inc.Insider Buying & Weekly Watchlist for Consistent Profits - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - Fundação Cultural do Pará
Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com
Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance
What momentum shifts mean for 10x Genomics Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Globe and Mail
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Motley Fool
Cookson Peirce & Co. Inc. Takes Position in 10x Genomics $TXG - MarketBeat
SPT Labtech and 10x Genomics Partner To Automate Single Cell Workflows - Technology Networks
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com
Why 10x Genomics Inc. (1KJ) stock trades below fair valueQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Will 10x Genomics Inc. stock gain from lower inflationEarnings Miss & Fast Gain Stock Trading Tips - newser.com
10x Genomics Hits Illumina With 2 Gene Tech Patent Suits - Law360
10x sues rival Illumina over gene-sequencing patents - Reuters
10x Genomics (TXG) Takes Legal Action Against Illumina Over Pate - GuruFocus
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - Seeking Alpha
Illumina Hit with 10X Genomics Patent Suits Over Sequencing Tech - Bloomberg Law News
10x Genomics, Inc. (TXG) Stock Analysis: A 13.07% Potential Upside In Health Information Services - DirectorsTalk Interviews
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance
10x Genomics partners with Anthropic to make biology research more accessible - Investing.com Canada
10X Genomics (TXG) Partners with Anthropic to Simplify Scientifi - GuruFocus
Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
10X Genomics to integrate analysis tools into Anthropic's Claude for Life Sciences - Seeking Alpha
10x Genomics partners with Anthropic to make biology research more accessible By Investing.com - Investing.com South Africa
10x Genomics Partners With Anthropic To Bring AI Tools For Researchers - Stocktwits
10x Genomics & Anthropic partner to make single cell & spatial analysis more accessible - MarketScreener
10x Genomics, Inc. and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences - MarketScreener
Why Is 10x Genomics (TXG) Stock Rocketing Higher Today - Yahoo Finance
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.38%
0.07%
자본화:
|
볼륨(24시간):